000022772 001__ 22772
000022772 005__ 20210129210830.0
000022772 0247_ $$2DOI$$a10.2967/jnumed.112.105114
000022772 0247_ $$2ISSN$$a0161-5505
000022772 0247_ $$2WOS$$aWOS:000311128400016
000022772 0247_ $$2altmetric$$aaltmetric:941778
000022772 0247_ $$2pmid$$apmid:22966134
000022772 037__ $$aPreJuSER-22772
000022772 082__ $$a610
000022772 1001_ $$0P:(DE-Juel1)131679$$aElmenhorst, D$$b0$$uFZJ
000022772 245__ $$aCaffeine Occupancy of Human Cerebral A1 Adenosine Receptors: In Vivo Quantification with 18F-CPFPX and PET
000022772 260__ $$aReston, Va.$$bSNM84042$$c2012
000022772 264_1 $$2Crossref$$3online$$bSociety of Nuclear Medicine$$c2012-09-10
000022772 264_1 $$2Crossref$$3print$$bSociety of Nuclear Medicine$$c2012-11-01
000022772 264_1 $$2Crossref$$3print$$bSociety of Nuclear Medicine$$c2012-11-01
000022772 300__ $$a1723 - 1729
000022772 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article
000022772 3367_ $$2DataCite$$aOutput Types/Journal article
000022772 3367_ $$00$$2EndNote$$aJournal Article
000022772 3367_ $$2BibTeX$$aARTICLE
000022772 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000022772 3367_ $$2DRIVER$$aarticle
000022772 440_0 $$03621$$aJournal of Nuclear Medicine$$v53$$x0097-9058$$y11
000022772 500__ $$aRecord converted from VDB: 16.11.2012
000022772 536__ $$0G:(DE-Juel1)FUEK409$$2G:(DE-HGF)$$aFunktion und Dysfunktion des Nervensystems (FUEK409)$$cFUEK409$$x0
000022772 536__ $$0G:(DE-HGF)POF2-89571$$a89571 - Connectivity and Activity (POF2-89571)$$cPOF2-89571$$fPOF II T$$x1
000022772 7001_ $$0P:(DE-Juel1)VDB68281$$aMeyer, P.T.$$b1$$uFZJ
000022772 7001_ $$0P:(DE-Juel1)138474$$aMatusch, A.$$b2$$uFZJ
000022772 7001_ $$0P:(DE-Juel1)VDB83077$$aWinz, O.H.$$b3$$uFZJ
000022772 7001_ $$0P:(DE-Juel1)131672$$aBauer, A.$$b4$$uFZJ
000022772 77318 $$2Crossref$$3journal-article$$a10.2967/jnumed.112.105114$$b : Society of Nuclear Medicine, 2012-09-10$$n11$$p1723-1729$$tJournal of Nuclear Medicine$$v53$$x0161-5505$$y2012
000022772 773__ $$0PERI:(DE-600)2040222-3$$a10.2967/jnumed.112.105114$$gVol. 53, no. 11, p. 1723 - 1729$$n11$$p1723-1729$$q53:11<1723 - 1729$$tJournal of nuclear medicine$$v53$$x0161-5505$$y2012
000022772 8567_ $$uhttp://dx.doi.org/10.2967/jnumed.112.105114
000022772 909CO $$ooai:juser.fz-juelich.de:22772$$pVDB
000022772 9141_ $$y2012
000022772 915__ $$0StatID:(DE-HGF)0040$$2StatID$$aPeer review unknown
000022772 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR
000022772 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000022772 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000022772 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000022772 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000022772 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000022772 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000022772 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000022772 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000022772 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000022772 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000022772 9132_ $$0G:(DE-HGF)POF3-571$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vConnectivity and Activity$$x0
000022772 9131_ $$0G:(DE-HGF)POF2-89571$$1G:(DE-HGF)POF3-890$$2G:(DE-HGF)POF3-800$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vConnectivity and Activity$$x1
000022772 9201_ $$0I:(DE-Juel1)INM-2-20090406$$gINM$$kINM-2$$lMolekulare Organisation des Gehirns$$x0
000022772 970__ $$aVDB:(DE-Juel1)139531
000022772 980__ $$aVDB
000022772 980__ $$aConvertedRecord
000022772 980__ $$ajournal
000022772 980__ $$aI:(DE-Juel1)INM-2-20090406
000022772 980__ $$aUNRESTRICTED